# MESA LABORATORIES INC /CO (MLAB) · Edgar & Edgarette company card

> Mesa Laboratories (MLAB) grew revenue 3.4% in FY2026 to $249 million, operating margin 7.4% against a 16.3% median for industrial instruments for measurement, display, and control, equity 43.5% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 724004 · fiscal year ended 2026-03-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/MLAB) · [JSON](https://www.pops4.com/boards/company/MLAB.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $249M |
| Revenue growth, 1 year | 3.4% |
| Revenue growth per year | 7.8% |
| Operating margin | 7.4% (prior year 6.8%) |
| Net margin | 2.7% |
| Operating cash flow | $43M |
| Capital spending | $3M |
| Free cash flow | $40M |
| Cash | $27M |
| Long-term debt | $68M |
| Total assets | $428M |
| Total equity | $186M |
| Equity ÷ assets | 43.5% |
| Return on equity | 3.6% |
| Dividend per share | $0.64 |
| Dividend years rising | 0 |

## Readings, computed from those figures

- Altman Z: 0.37 (distress zone)
- Piotroski F: 8 of 9 (strong)
- Health Harbor boat: Sound ship · one warning sign · filed restructuring or exit costs in the last 12 months
- Cash Compass: Cash cow now · steady, with strong cash arriving today

## Edgarette's reading

Exposure: revenue $249.1M (FY2026), total debt $67.5M. Experience: revenue up 3.4% on the year, up 7.8% a year over 4 years; operating margin 7.4%, up from 6.8%. Soundness: equity 43.5% of assets, return on equity 3.6%, payout 52.5% of profit. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $208.9M and $308.6M next year (method v4.1: its own 5-year record of growth weighed at 57% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $189.3M to $341.9M. A statistical range, not company guidance. Against peers (11 filers, $50M+ revenue, industrial instruments for measurement, display, and control): operating margin 7.4% against a 16.3% median; growth 3.4% against 3.4%.

Range logged 2026-09-28, receipt 153aa21d09f15d6b, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 2.05 Restructuring or exit costs: 1, latest 2026-10-13 ([filing](https://www.sec.gov/Archives/edgar/data/724004/000143774926032499/0001437749-26-032499-index.htm))
- Item 5.02 Director or officer change: 3, latest 2026-06-15 ([filing](https://www.sec.gov/Archives/edgar/data/724004/000072400426000056/0000724004-26-000056-index.htm))

## Recent filings

- 8-K · filed 2026-10-13 · 2.05 Costs Associated with Exit or Disposal Activities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/724004/000143774926032499/0001437749-26-032499-index.htm)
- 8-K · filed 2026-09-08 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/724004/000143774926029813/0001437749-26-029813-index.htm)
- 10-Q · filed 2026-08-10 · [filing](https://www.sec.gov/Archives/edgar/data/724004/000143774926026808/0001437749-26-026808-index.htm)
- 8-K · filed 2026-08-10 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/724004/000143774926026769/0001437749-26-026769-index.htm)
- 8-K · filed 2026-07-30 · 5.05 Amendments to the Code of Ethics; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/724004/000072400426000082/0000724004-26-000082-index.htm)
- DEF 14A · filed 2026-07-22 · [filing](https://www.sec.gov/Archives/edgar/data/724004/000072400426000071/0000724004-26-000071-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000724004.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=724004

## Cite

POPS4, Edgar & Edgarette: MESA LABORATORIES INC /CO (MLAB) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/MLAB. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.